Noteworthy, the inhibition of DPPIV catalytic activity in Hep3B cells is synergistic, indicating that the mixture of these phytochemicals can counteract the establishment of a hyperglycemia condition and can inhibit the molecular pathways of insulin resistance that lead to T2DM development. The gene discussed is DPP4; the disease is Hyperglycemia.